A Two-Step Mechanism for Recruitment of Pip by PU.1
Open accessAbstract
Transcription of the Ig κ light chain gene is controlled in part by the 3′ κ enhancer. Two of the proteins that bind to the 3′ enhancer, PU.1 and Pip, show tissue-restricted expression and may be responsible for the tissue specificity of 3′ enhancer activity. PU.1 alone can bind to DNA; however, Pip cannot bind to its 3′ enhancer site in electrophoretic mobility shift assays, unless recruited by PU.1. Previously, we showed that the PU.1 PEST domain (rich in the amino acids proline, glutamate, serine, and threonine; sequences 118–160) is necessary for Pip recruitment to DNA. Here we used detailed mutagenic analyzes of PU.1 to more precisely identify sequences required for Pip recruitment by electrophoretic mobility shift assay. We found that mutation of three segments within the PU.1 PEST domain (118–125, 133–139, and 141–147) modulated the efficiency of Pip recruitment, while mutation of sequences between residues 88–118 and 154–168 had no effect. Interestingly, we found that the PU.1 ETS domain (residues 170 to 255) is both necessary and sufficient for Pip interaction in solution and that other ETS domain proteins can physically interact with Pip as well. Our results suggest that Pip recruitment to DNA by PU.1 occurs via a two-step mechanism. First, a physical interaction that is not sufficient to recruit Pip occurs via the PU.1 ETS domain. Second, a conformational change in the PU.1 PEST domain, apparently mediated by serine phosphorylation, induces a conformational change in Pip enabling it to bind to DNA. We also show that the PU.1 PEST domain does not target PU.1 for rapid turnover.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PU.1 forms complexes with IRF-4 and IRF-8 to drive cofactor-dependent expression, such as Toll-like receptor 4.
“Notably, besides transcription of genes that is directly dependent on PU.1mediated transactivation, PU.1 is also able to form complexes with cofactors as IRF-4 and IRF-8 to induce cofactordependent expression, for example, of Toll-like receptor 4 [50][51][52].”
From PKCδ-Induced PU.1 Phosphorylation Promotes Hematopoietic Stem Cell Differentiation to Dendritic Cells (2011) · cites this paper as [52]
The paper's Abstract (page not provided) identifies Pip as IRF4 and describes its recruitment by PU.1 to immunoglobulin enhancer DNA-binding sites. The passages support PU.1–IRF4 cooperation, but do not address PU.1 complexes with IRF8 or cofactor-dependent expression of Toll-like receptor 4. (LLM, conf=0.88)
Experimental — accuracy not yet measuredA recent study suggests PU.1 and Pip can interact in the absence of template DNA.
“A recent study using protein-protein interaction assays suggests that PU.1 and Pip can interact in the absence of template DNA”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Perkel et al., 1998
In the two-step recruitment mechanism for PU.1/Pip ternary complex, PU.1/Pip interaction is DNA template-directed and involves two distinct protein-protein interaction surfaces: (i) the ETS (PU.1) and IRF (Pip) DNA binding domains and (ii) the phosphorylated PEST domain of PU.1 and a putative α helix in Pip.
“A model was proposed for PU.1/Pip ternary complex. In this two-step recruitment mechanism, PU.1/Pip interaction is DNA template-directed and involves two distinct protein–protein interaction surfaces: (i) the ETS (PU.1) and IRF (Pip) DNA binding domains and (ii) the phosphorylated PEST domain of PU.1 and a putative α helix in Pip [118, 119] (Fig. 9).”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [118]
The PU.1-ICSBP interaction is DNA directed and facilitated by EICE.
“Analogous to the PU.1-Pip interaction, the PU.1-ICSBP interaction is DNA directed and facilitated by EICE (4, 38).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [38]
The PU.1-ICSBP interaction is dependent on the IAD domain in the C-terminal region, although the DBD is also required.
“the PU.1-ICSBP interaction is dependent on the IAD domain in the C-terminal region, although the DBD is also required for this interaction (5, 38).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [38]
ICSBP has been known to interact with PU.1, a hematopoietic-cell-specific member of the Ets family.
“ICSBP has been known to interact with PU.1, a hematopoietic-cellspecific member of the Ets family (4, 5, 38).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,262 · see citing works
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,734 · see citing works
Site-directed mutagenesis by overlap extension using the polymerase chain reaction
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., & Pease, L. R. (1989) · Gene · doi:10.1016/0378-1119(89)90358-2 · Cited by 7,354 · see citing works
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,754 · see citing works
Amino Acid Sequences Common to Rapidly Degraded Proteins: The PEST Hypothesis
Rogers, S. W., Wells, R., & RECHSTEINER, M. C. (1986) · Science · doi:10.1126/science.2876518 · Cited by 2,565 · see citing works
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · see citing works
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954 · see citing works
Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Mittrücker, H.-W., Matsuyama, T., Grossman, A., Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S., & Mak, T. W. (1997) · Science · doi:10.1126/science.275.5299.540 · Cited by 583 · see citing works
Kaelin, W. G., Pallas, D. C., DeCaprio, J. A., Kaye, F. J., & Livingston, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90236-r · Cited by 518 · see citing works
Spi-1 is a putative oncogene in virally induced murine erythroleukaemias
Moreau-Gachelin, F., Tavitian, A., & Tambourin, P. (1988) · Nature · doi:10.1038/331277a0 · Cited by 447 · see citing works
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447 · see citing works
Park, K., & Atchison, M. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9804 · Cited by 363 · see citing works
Self-citationPongubala, J. M., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A., & Atchison, M. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.368 · Cited by 354 · see citing works
Self-citationHagemeier, C., Bannister, A. J., Cook, A., & Kouzarides, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1580 · Cited by 303 · see citing works
Hohaus, S., Petrovick, M. S., Voso, M. T., Sun, Z., Zhang, D.-E., & Tenen, D. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5830 · Cited by 284 · see citing works
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
Pongubala, J., Van Beveren, C., Nagulapalli, S., Klemsz, M., McKercher, Maki, R., & Atchison, M. (1993) · Science · doi:10.1126/science.8456286 · Cited by 282 · cited 5× · see citing works
“These sequences (Ser-Asp-Glu-Glu-Glu-Gly-Glu-Val) constitute a consensus sequence for CKII.”
BackgroundInfluentialSelf-citationBrass, A. L., Kehrli, E., Eisenbeis, C. F., Storb, U., & Singh, H. (1996) · Genes & Development · doi:10.1101/gad.10.18.2335 · Cited by 242 · see citing works
Matsuyama, T., Grossman, A., Mittrücker, H.-W., Siderovski, D. P., Kiefer, F., Kawakami, T., Richardson, C. D., Taniguchi, T., Yoshinaga, S. K., & Mak, T. W. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.12.2127 · Cited by 232 · see citing works
Atchison, M. L., & Perry, R. P. (1987) · Cell · doi:10.1016/0092-8674(87)90362-x · Cited by 232 · see citing works
Self-citationMeyer, K. B., & Neuberger, M. S. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03601.x · Cited by 214 · see citing works
Yamagata, T., Nishida, J., Tanaka, T., Sakai, R., Mitani, K., Yoshida, M., Taniguchi, T., Yazaki, Y., & Hirai, H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1283 · Cited by 196 · see citing works
Olson, M. C., Scott, E. W., Hack, A. A., Su, G. H., Tenen, D. G., Singh, H., & Simon, M. C. (1995) · Immunity · doi:10.1016/1074-7613(95)90060-8 · Cited by 191 · see citing works
Spi-1/PU.1 Transgenic Mice Develop Multistep Erythroleukemias
Moreau-Gachelin, F., Wendling, F., Molina, T., Denis, N., Titeux, M., Grimber, G., Briand, P., Vainchenker, W., & Tavitian, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2453 · Cited by 189 · see citing works
Eisenbeis, C. F., Singh, H., & Storb, U. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6452 · Cited by 182 · see citing works
c-myc and c-myb Protein Degradation: Effect of Metabolic Inhibitors and Heat Shock
Lüscher, B., & Eisenman, R. N. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.6.2504 · Cited by 148 · see citing works
Kominato, Y., Galson, D. L., Waterman, W. R., Webb, A. C., & Auron, P. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.59 · Cited by 146 · see citing works
Inhibition of hematopoiesis by competitive binding of transcription factor PU.1
Voso, M. T., Burn, T. C., Wulf, G., Lim, B., Leone, G., & Tenen, D. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.7932 · Cited by 141 · see citing works
Moreau-Gachelin, F., Ray-Gallet, D., Mattéi, M., Tambourin, P. E., & Tavitian, A. (1989) · PubMed · Cited by 138 · see citing works
Shin, M. K., & Koshland, M. E. (1993) · Genes & Development · doi:10.1101/gad.7.10.2006 · Cited by 126 · see citing works
Paul, R., Schuetze, S., Kozak, S. L., Kozak, C. A., & Kabat, D. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.464-467.1991 · Cited by 113 · see citing works
Nagulapalli, S., Pongubala, J. M., & Atchison, M. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4330 · Cited by 110 · see citing works
Self-citationLodie, T. A., Savedra, R., Golenbock, D. T., Van Beveren, C. P., Maki, R. A., & Fenton, M. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1848 · Cited by 110 · cited 1× · see citing works
“1 conformational change is provided by the work of Lodie and coworkers (33), who showed that PU.”
MethodPU.1 Recruits a Second Nuclear Factor to a Site Important for Immunoglobulin κ 3' Enhancer Activity
Pongubala, J. M. R., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A., & Atchison, M. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.368-378.1992 · Cited by 105 · see citing works
Self-citationEts Proteins: New Factors That Regulate Immunoglobulin Heavy-Chain Gene Expression
Rivera, R. R., Stuiver, M. H., Steenbergen, R. D. M., & Murre, C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.7163 · Cited by 99 · see citing works
Activation of Transcription by PU.1 Requires both Acidic and Glutamine Domains
Klemsz, M. J., & Maki, R. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.390 · Cited by 93 · see citing works
The Ets-Related Transcription Factor PU.1 Immortalizes Erythroblasts
Schuetze, S. M., Stenberg, P. E., & Kabat, D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5670 · Cited by 87 · see citing works
PU.1 can participate in an active enhancer complex without its transcriptional activation domain
Pongubala, J. M. R., & Atchison, M. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.127 · Cited by 86 · see citing works
Self-citationCharacterization of the ets oncogene family member, fli-1.
Klemsz, M. J., Maki, R. A., Papayannopoulou, T., Moore, J., & Hromas, R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53385-8 · Cited by 84 · see citing works
Functional interference between the Spi‐1/PU.1 oncoprotein and steroid hormone or vitamin receptors.
Gauthier, J. M., Bourachot, B., Doucas, V., Yaniv, M., & Moreau-Gachelin, F. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06203.x · Cited by 58 · see citing works
The Ets-Related Transcription Factor PU.1 Immortalizes Erythroblasts
Schuetze, S. M., Stenberg, P. E., & Kabat, D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5670-5678.1993 · Cited by 42 · see citing works
Pongubala, J. M. R., & Atchison, M. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.10304 · Cited by 38 · see citing works
Self-citationBuras, J. A., Reenstra, W. R., & Fenton, M. J. (1995) · Molecular Immunology · doi:10.1016/0161-5890(95)00018-a · Cited by 34 · see citing works
Inaba, T., Gotoda, T., Ishibashi, S., Harada, K., Ohsuga, J.-I., Ohashi, K., Yazaki, Y., & Yamada, N. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2264 · Cited by 28 · see citing works
Costa, M. W., & Atchison, M. L. (1996) · Biochemistry · doi:10.1021/bi952801y · Cited by 13 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Falini, B., Fizzotti, M., Pucciarini, A., Bigerna, B., Marafioti, T., Gambacorta, M., Pacini, R., Alunni, C., Natali–Tanci, L., Ugolini, B., et al. (2000) · Blood · doi:10.1182/blood.v95.6.2084 · Cited by 471 · see citing works
Signal transduction and the Ets family of transcription factors
Yordy, J. S., & Muise‐Helmericks, R. C. (2000) · Oncogene · doi:10.1038/sj.onc.1204036 · Cited by 325 · see citing works
Critical roles of interferon regulatory factor 4 in CD11b high CD8α – dendritic cell development
Suzuki, S., Honma, K., Matsuyama, T., Suzuki, K. T., Toriyama, K., Akitoyo, I., Yamamoto, K., Suematsu, T., Nakamura, M., Yui, K., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402139101 · Cited by 317 · see citing works
Regulation of Ets function by protein–protein interactions
Li, R., Pei, H., & Watson, D. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204035 · Cited by 229 · see citing works
Brass, A. L., Zhu, A. Q., & Singh, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.977 · Cited by 207 · see citing works
Analysis of MUM1/IRF4 Protein Expression Using Tissue Microarrays and Immunohistochemistry
Natkunam, Y., Warnke, R. A., Montgomery, K. D., Falini, B., & van de Rijn, M. (2001) · Modern Pathology · doi:10.1038/modpathol.3880373 · Cited by 175 · see citing works
Lubyová, B., & Pitha, P. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8194-8201.2000 · Cited by 174 · see citing works
Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease
Antonczyk, A., Krist, B., Sajek, M., Sekrecka, A., Piaszyk-Borychowska, A., Plens-Gałąska, M., Wesoły, J., & Bluyssen, H. A. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01176 · Cited by 156 · see citing works
Meraro, D., Hashmueli, S., Koren, B., Azriel, A., Oumard, A., Kirchhoff, S., Hauser, H., Nagulapalli, S., Atchison, M. L., & Levi, B.-Z. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6468 · Cited by 147 · see citing works
Self-citationThe diverse roles of IRF4 in late germinal center B‐cell differentiation
Silva, N. S. D., Simonetti, G., Heise, N., & Klein, U. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01113.x · Cited by 141 · see citing works
When Ets transcription factors meet their partners
Verger, A., & Duterque‐Coquillaud, M. (2002) · BioEssays · doi:10.1002/bies.10068 · Cited by 134 · see citing works
Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU. 1 complex
Kanno, Y., Levi, B.-Z., Tamura, T., & Ozato, K. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.770 · Cited by 128 · see citing works
Luchin, A. I., Suchting, S., Merson, T. D., Rosol, T. J., Hume, D. A., Cassady, A. I., & Ostrowski, M. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106418200 · Cited by 123 · see citing works
Lehtonen, A., Veckman, V., Nikula, T., Lahesmaa, R., Kinnunen, L., Matikainen, S., & Julkunen, I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6570 · Cited by 112 · see citing works
Marecki, S., Riendeau, C. J., Liang, M. D., & Fenton, M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6829 · Cited by 111 · see citing works
Meraro, D., Gleit-Kielmanowicz, M., Hauser, H., & Levi, B.-Z. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6224 · Cited by 105 · see citing works
Scott, M. J., Pan, L. L., Cleland, S. B., Knox, A. L., & Heinrich, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.1.144 · Cited by 102 · see citing works
The Transcriptional Repressor GFI-1 Antagonizes PU.1 Activity through Protein-Protein Interaction
Dahl, R. E., Iyer, S. R., Owens, K., Cuylear, D. D., & Simon, M. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607613200 · Cited by 93 · see citing works
Marecki, S., Atchison, M. L., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2713 · Cited by 87 · see citing works
Self-citationIRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?
Biswas, P. S., Bhagat, G., & Pernis, A. B. (2009) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00864.x · Cited by 81 · see citing works
Frederick, M. A., Williamson, K. E., García, M. F., Ferretti, M., McCarthy, R. L., Donahue, G., Luzete-Monteiro, E., Takenaka, N., Reynaga, J., Kadoch, C., et al. (2022) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00886-5 · Cited by 79 · see citing works
Gupta, P., Gurudutta, G. U., Saluja, D., & Tripathi, R. P. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00757.x · Cited by 74 · see citing works
PU.1/Interferon Regulatory Factor Interactions; Mechanisms of Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:33:2:127 · Cited by 74 · see citing works
Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1
Hong, W., Kim, A. Y., Ky, S., Rakowski, C., Seo, S.-B., Chakravarti, D., Atchison, M., & Blobel, G. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3729-3743.2002 · Cited by 71 · see citing works
Self-citationReview: ICSBP/IRF-8 Transactivation: A Tale of Protein-Protein Interaction
Levi, B.-Z., Hashmueli, S., Gleit-Kielmanowicz, M., Azriel, A., & Meraro, D. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452764 · Cited by 70 · see citing works
Kuwata, T., Gongora, C., Kanno, Y., Sakaguchi, K., Tamura, T., Kanno, T., Basrur, V., Martinez, R., Appella, E., Golub, T., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7439-7448.2002 · Cited by 69 · see citing works
Lety, M. A., Fréhel, C., Dubail, I., Béretti, J., Kayal, S., Berche, P., & Charbit, A. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02281.x · Cited by 69 · see citing works
IRF8‐dependent Molecular Complexes Control the Th9 Transcriptional Program
Humblin, E., Thibaudin, M., Chalmin, F., Derangère, V., Limagne, E., Richard, C., Flavell, R. A., Chevrier, S., Ladoire, S., Berger, H., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01070-w · Cited by 67 · see citing works
Review: The Role of IRF-4 in Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452737 · Cited by 67 · see citing works
BSAP Can Repress Enhancer Activity by Targeting PU.1 Function
Maitra, S., & Atchison, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.1911-1922.2000 · Cited by 72 · see citing works
Self-citationReview: The Role of IRF-4 in B and T Cell Activation and Differentiation
Pernis, A. B. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452728 · Cited by 62 · see citing works
van der Stoep, N., Quinten, E., Rezende, M. M., & van den Elsen, P. J. (2004) · Blood · doi:10.1182/blood-2004-03-0790 · Cited by 56 · see citing works
Unlu, S., Kumar, A., Waterman, W. R., Tsukada, J., Wang, K. Z. Q., Galson, D. L., & Auron, P. E. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.02.016 · Cited by 55 · see citing works
O’Reilly, D., Quinn, C. M., El‐Shanawany, T., Gordon, S., & Greaves, D. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212150200 · Cited by 55 · see citing works
Rieske, P., & Pongubala, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007482200 · Cited by 53 · see citing works
Stage-Specific Modulation of IFN-Regulatory Factor 4 Function by Kruppel-Type Zinc Finger Proteins
Gupta, S. K., Anthony, A., & Pernis, A. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6104 · Cited by 49 · see citing works
Laricchia‐Robbio, L., Tamura, T., Karpova, T., Sprague, B. L., McNally, J. G., & Ozato, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504014102 · Cited by 47 · see citing works
Kim, J., & Feldman, R. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1903-1918.2002 · Cited by 46 · see citing works
Hamdorf, M., Berger, A., Schüle, S., Reinhardt, J., & Flory, E. (2011) · Stem Cells · doi:10.1002/stem.564 · Cited by 45 · see citing works
Cohen, H., Azriel, A., Cohen, T., Meraro, D., Hashmueli, S., Bech-Otschir, D., Kraft, R., Dubiel, W., & Levi, B.-Z. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004900200 · Cited by 45 · see citing works
Rapid structural and epigenetic changes in polyploid and aneuploid genomes
Matzke, M. A., Scheid, O. M., & Matzke, A. J. M. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199909)21:9 · Cited by 151 · see citing works
Zápražná, K., & Atchison, M. L. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05989-11 · Cited by 43 · see citing works
Self-citationAlter-Koltunoff, M., Ehrlich, S., Dror, N., Azriel, A., Eilers, M., Häuser, H., Bowen, H., Barton, C. H., Tamura, T., Ozato, K., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307954200 · Cited by 41 · see citing works
Specificity and Function of IRF Family Transcription Factors: Insights from Genomics
Mancino, A., & Natoli, G. (2016) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0004 · Cited by 39 · see citing works
Protein Acetylation Regulates Both PU.1 Transactivation and Igκ 3′ Enhancer Activity
Bai, Y., Srinivasan, L., Perkins, L., & Atchison, M. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5160 · Cited by 38 · see citing works
Self-citationStructural Studies of IRF4 Reveal a Flexible Autoinhibitory Region and a Compact Linker Domain
Remesh, S. G., Santosh, V., & Escalante, C. R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.678789 · Cited by 33 · see citing works
Mishra, M., Thacker, G., Sharma, A., Singh, A. K., Upadhyay, V., Sanyal, S., Verma, S. P., Tripathi, A. K., Bhatt, M. L. B., & Trivedi, A. K. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0268 · Cited by 30 · see citing works
Spi-1/PU.1 Oncoprotein Affects Splicing Decisions in a Promoter Binding-dependent Manner
Guillouf, C., Gallais, I., & Moreau-Gachelin, F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512049200 · Cited by 30 · see citing works
PU.1 Can Recruit BCL6 to DNA To Repress Gene Expression in Germinal Center B Cells
Wei, F., Zápražná, K., Wang, J., & Atchison, M. L. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00234-09 · Cited by 30 · see citing works
Self-citationIntrinsic disorder controls two functionally distinct dimers of the master transcription factor PU.1
Xhani, S., Lee, S., Kim, H. M., Wang, S., Esaki, S., Ha, V. L., Khanezarrin, M., Fernandez, G. L., Albrecht, A. V., Aramini, J. M., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay3178 · Cited by 29 · see citing works
Delva, L., Gallais, I., Guillouf, C., Denis, N., Orvain, C., & Moreau-Gachelin, F. (2004) · Oncogene · doi:10.1038/sj.onc.1207578 · Cited by 26 · see citing works
The Igκ3′ Enhancer Is Activated by Gradients of Chromatin Accessibility and Protein Association
McDevit, D. C., Perkins, L., Atchison, M. L., & Nikolajczyk, B. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2834 · Cited by 26 · see citing works
Self-citationPedchenko, T. V., Park, G. Y., Joo, M., Blackwell, T. S., & Christman, J. W. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00046.2005 · Cited by 24 · see citing works
DNA Binding Regulates the Self-Association of the ETS Domain of PU.1 in a Sequence-Dependent Manner
Poon, G. M. K. (2012) · Biochemistry · doi:10.1021/bi300331v · Cited by 23 · see citing works
Hematopoietic Stem Cell Molecular Targets and Factors Essential for Hematopoiesis
Raghav, P. K., & Gangenahalli, G. U. (2018) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000441 · Cited by 21 · see citing works
PU.1 Regulates Cathepsin S Expression in Professional APCs
Wang, Y., Baron, R. M., Zhu, G., Joo, M., Christman, J. W., Silverman, E. S., Perrella, M. A., Riese, R. J., & Cernadas, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.275 · Cited by 21 · see citing works
Context-dependent Pax-5 repression of a PU.1/NF-κB regulated reporter gene in B lineage cells
Linderson, Y., French, N. S., Neurath, M. F., & Pettersson, S. (2001) · Gene · doi:10.1016/s0378-1119(00)00546-1 · Cited by 19 · see citing works
Hines, R., Sorensen, B. R., Shea, M. A., & Maury, W. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3407-3418.2004 · Cited by 19 · see citing works
Backbone dynamics of a short PU.1 ETS domain 1 1Edited by P. E. Wright
Jia, X., Lee, L. K., Light, J. P., Palmer, A. G. I., & Assa‐Munt, N. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3123 · Cited by 18 · see citing works
Crystallization and characterization of PU.1/IRF-4/DNA ternary complex
Escalante, C. R., Shen, L., Escalante, M. C., Brass, A. L., Edwards, T. A., Singh, H., & Aggarwal, A. K. (2002) · Journal of Structural Biology · doi:10.1016/s1047-8477(02)00514-2 · Cited by 17 · see citing works
McKercher, S. R., Lombardo, C. R., Bobkov, A. A., Jia, X., & Assa‐Munt, N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0136910100 · Cited by 14 · see citing works
Azim, A. C., Wang, X., Park, G. Y., Sadikot, R. T., Cao, H., Mathew, B., Atchison, M., van Breemen, R. B., Joo, M., & Christman, J. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7868 · Cited by 13 · see citing works
Self-citationKihara-Negishi, F., Suzuki, M., Yamada, T., Sakurai, T., & Oikawa, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.098 · Cited by 13 · see citing works
Nakano, N., Nishiyama, C., Masuoka, N., Nishiyama, M., Yamane, H., Okumura, K., & Ogawa, H. (2005) · Immunogenetics · doi:10.1007/s00251-004-0754-2 · Cited by 11 · see citing works
Sp2 regulates interferon-γ-mediated socs1 gene expression
Letourneur, M., Valentino, L., Travagli-Gross, J., Bertoglio, J. H., & Pierre, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.05.004 · Cited by 10 · see citing works
Hodawadekar, S., Park, K., Farrar, M. A., & Atchison, M. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102239 · Cited by 10 · see citing works
Self-citationHashmueli, S. (2003) · International Immunology · doi:10.1093/intimm/dxg077 · Cited by 9 · see citing works
E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding
Rogers, J. H., Owens, K., Kurkewich, J. L., Klopfenstein, N., Iyer, S. R., Simon, M. C., & Dahl, R. E. (2016) · BioMed Research International · doi:10.1155/2016/3983686 · Cited by 7 · see citing works
Phosphorylation of the Spi‐B transcription factor reduces its intrinsic stability
Ray-Gallet, D., & Moreau-Gachelin, F. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01687-7 · Cited by 7 · see citing works
Hodawadekar, S., Wei, F., Yu, D., Thomas‐Tikhonenko, A., & Atchison, M. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6165 · Cited by 7 · see citing works
Self-citationPulugulla, S. H., Workman, R. J., Rutter, N., Yang, Z., Adamik, J., Lupish, B., Macar, D. A., el Abdouni, S., Esposito, E. X., Galson, D. L., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005627 · Cited by 6 · see citing works
Role of IRF4-Mediated Inflammation: Implication in Neurodegenerative Diseases
Liu, F. (2017) · Neurology & Neurotherapy Open Access Journal · doi:10.23880/nnoaj-16000107 · Cited by 5 · see citing works
Expression and activation of STAT and IRF family transcription factors in mononuclear leukocytes
Lehtonen, A. (2005) · Työväentutkimus Vuosikirja
The role of PU.1 and IRF4 interaction in the biology and function of T helper 2 cells
Ahyi, A.-N. N. (2009) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1686
Li, Y., Hirano, S., Sato, K., Osawa, M., & Nagaoka, H. (2024) · Biochemistry · doi:10.1021/acs.biochem.3c00512
Jaeger, R. A., Roberts, N. A., Turnbull, C. M., Seneviratne, S., Buckland, R. L., Spensberger, D., Pettitt, J. A., Ballard, F. D., Brüstle, A., & Enders, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.25.661400
- Authors
- Perkel, J. M., & Atchison, M. L.
- Affiliations
- University of Pennsylvania (US)
- ORCID
- Perkel, Jeffrey M
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-01-01
- Volume
- 160
- Issue
- 1
- Pages
- 241-252
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1543294597
- Cited by
- 77
- References
- 43
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 1 · 2012: 4
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (GM-42415, R01GM042415)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- PU.1, Pip, transcriptional regulation, protein-protein interaction, PEST domain, ETS domain, serine phosphorylation, protein conformational change, DNA binding, protein turnover, tissue specificity
- MeSH terms
- Proto-Oncogene Protein Spi-1, Amino Acid Sequence, Animals, Bacterial Proteins, Binding Sites, DNA-Binding Proteins, Enhancer Elements, Genetic, Gene Expression Regulation, Immunoglobulin kappa-Chains, Membrane Proteins, Molecular Sequence Data, Nuclear Proteins, Protein Binding, Proto-Oncogene Proteins, Transcription Factors, Trans-Activators, 3T3 Cells, Proto-Oncogene Proteins c-ets, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review